Bhat AN, Landa RJ, Galloway JC Current perspectives on motor functioning in infants, children, and adults with autism spectrum disorders. Phys Ther. 2011 Jul;91(7):1116-29. doi: 10.2522/ptj.20100294. Epub 2011 May 5.
Cesaroni L, Garber M Exploring the experience of autism through firsthand accounts. J Autism Dev Disord. 1991 Sep;21(3):303-13.
Einspieler C, Sigafoos J, Bölte S, Bratl-Pokorny KD, Landa R, Marschik PB Highlighting the first 5 months of life: General movements in infants later diagnosed with autism spectrum disorder or Rett Syndrome. Res Autism Spectr Disord. 2014 Mar;8(3):286-291. doi: 10.1016/j.rasd.2013.12.013. Epub 2014 Jan 9.
Frith U, Happé F Autism: beyond "theory of mind". Cognition. 1994 Apr-Jun;50(1-3):115-32. Review.
Gyllensten, A L. (2012). Basal kroppskännedom. i G. Biguet, R. Keskinen-Rosenqvist, & A. Levy Berg, Att förstå kroppens signaler - sjukgymnastiska perspektiv (ss. 189-206). Lund: Studentlitteratur.
Gyllensten, A L., Hansson, L., & Ekdahl, C. (2003). Patient experiences of basic body awareness therapy and the relationship with the physiotherapist. Journal of Bodywork and Movement Therapies, 7, 173-183.
Hedlund, L (2014). Basal kroppskännedom och psykomotorisk funktion hos personer med allvarlig psykisk sjukdom. Doctoral thesis, Lund: Department of Health Science, Division of Physiotherapy.
Kopp S, Beckung E, Gillberg C Developmental coordination disorder and other motor control problems in girls with autism spectrum disorder and/or attention-deficit/hyperactivity disorder. Res Dev Disabil. 2010 Mar-Apr;31(2):350-61. doi: 10.1016/j.ridd.2009.09.017. Epub 2009 Nov 11.
Lai MC, Lombardo MV, Baron-Cohen S Autism. Lancet. 2014 Mar 8;383(9920):896-910. doi: 10.1016/S0140-6736(13)61539-1. Epub 2013 Sep 26. Review.
Norman, G , & Streiner, D. (2014). Biostatistics. The bare essentials. Ontario: PMPH-USA Limited.
Regeringskansliet (2008). FN:s konvention om rättigheter för personer med funktionsnedsättning. Hämtat från http://www.regeringen.se/contentassets/0b52fa83450445aebbf88827ec3eecb8/fns-konvention-om-rattigheter-for-personer-med-funktionsnedsattning-ds-200823
Rizzolatti G, Fabbri-Destro M Mirror neurons: from discovery to autism. Exp Brain Res. 2010 Jan;200(3-4):223-37. doi: 10.1007/s00221-009-2002-3. Epub 2009 Sep 18. Review.
Simons J, Leitschuh C, Raymaekers A, Vandenbussche I Body awareness in preschool children with psychiatric disorder. Res Dev Disabil. 2011 Sep-Oct;32(5):1623-30. doi: 10.1016/j.ridd.2011.02.011. Epub 2011 Mar 24.
Skjaerven, L , Gard, G., & Kristoffersen, K. (2003). Basic elements and dimensions to the phenomenon of quality of movement - a case study. Journal of bodywork and movement therapies.
Whyatt C, Craig C Sensory-motor problems in Autism. Front Integr Neurosci. 2013 Jul 18;7:51. doi: 10.3389/fnint.2013.00051. eCollection 2013.
Basic Body Awareness Therapy for Persons With Autism. A Pragmatic Randomized Controlled Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
